Skip to main content
Clinical Trials/TCTR20171114002
TCTR20171114002Not yet recruitingPhase 2

Efficacy and safety of adjunctive topical Bevacizumab eye drops in Trabeculectomy

Faculty of medicine,Khonkaen university0 sites38 target enrollmentStarted: November 14, 2017Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
38

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 0 N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • uncontrolled primary glaucoma and secondary glaucoma
  • vascularity score of Würzburg bleb classification score (WBCS) of post-operative bleb is <2 and/or Corkscrew vessels score < 3
  • older than 18 years old

Exclusion Criteria

  • post-operative hypotony, wound leak, flat anterior chamber,
  • suprachoroidal hemorrhage, choroidal detachment
  • One eye condition
  • neovascular glaucoma and uveitic glaucome
  • Recent Myocardial infarction or Stroke
  • During pregnancy or lactation

Investigators

Sponsor
Faculty of medicine&#44;Khonkaen university

Similar Trials